이동택 (Harvard Medical School)님 | 한빛사연구자 > 한빛사

Harvard Medical School

최종업데이트 2024.07.23.

Bioengineered amyloid peptide for rapid screening of inhibitors against main protease of SARS-CoV-2
- Nat. Commun., 07 March 2024 | https://doi.org/10.1038/s41467-024-46296-7
- 2024-03
- 바이오·의료융합
- 한빛사논문
Caco-2 cell-derived biomimetic electrochemical biosensor for cholera toxin detection
- Biosens. Bioelectron., 2023 Apr 15;226:115105 | https://doi.org/10.1016/j.bios.2023.115105
- 2023-04
- 바이오·의료융합
- 한빛사논문
PCR-like performance of rapid test with permselective tunable nanotrap
- Nat. Commun., 2023 Mar 18;14(1):1520 | https://doi.org/10.1038/s41467-023-37018-6
- 2023-03
- 바이오·의료융합
- 한빛사논문
Biomimetically Engineered Amyloid-Shelled Gold Nanocomplexes for Discovering α-Synuclein Oligomer-Degrading Drugs
- ACS Appl. Mater. Interfaces, December 22, 2022 | https://doi.org/10.1021/acsami.2c14650
- 2022-12
- 바이오·의료융합
- 한빛사논문
Plasmonic nanoparticle amyloid corona for screening Aβ oligomeric aggregate-degrading drugs
- Nat. Commun., Published 27 January 2021, 12, 639 | https://doi.org/10.1038/s41467-020-20611-4
- 2021-01
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문